Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Sarah Parker

Concepts (344)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antimicrobial Stewardship
11
2021
130
4.510
 Why?
Hospitals, Pediatric
22
2022
558
3.490
 Why?
Anti-Infective Agents
12
2021
232
3.370
 Why?
Anti-Bacterial Agents
35
2026
1925
3.020
 Why?
Osteomyelitis
10
2026
146
2.230
 Why?
Bacteremia
4
2025
222
2.100
 Why?
Arthritis, Infectious
8
2026
76
2.090
 Why?
Drug Utilization Review
6
2020
61
1.550
 Why?
Bacterial Infections
7
2025
246
1.400
 Why?
Blood Culture
4
2025
27
1.380
 Why?
Metronidazole
3
2019
20
1.180
 Why?
Staphylococcal Infections
6
2026
393
1.170
 Why?
Appendicitis
3
2019
150
1.060
 Why?
Child
51
2026
22739
1.020
 Why?
Otitis Media
4
2024
182
0.990
 Why?
Acute Disease
8
2025
1036
0.910
 Why?
Methicillin-Resistant Staphylococcus aureus
4
2026
251
0.880
 Why?
Kingella kingae
2
2022
12
0.850
 Why?
Intensive Care Units, Neonatal
2
2025
293
0.830
 Why?
Respiration, Artificial
3
2026
714
0.800
 Why?
Retrospective Studies
27
2025
17325
0.700
 Why?
Musculoskeletal System
1
2022
54
0.680
 Why?
Musculoskeletal Diseases
2
2025
91
0.670
 Why?
Surgical Wound Infection
2
2022
329
0.640
 Why?
Infant
23
2026
10090
0.590
 Why?
Humans
76
2026
145763
0.580
 Why?
Microbial Sensitivity Tests
6
2026
365
0.560
 Why?
Respiratory Tract Infections
1
2022
396
0.540
 Why?
Drug Resistance, Bacterial
3
2021
185
0.530
 Why?
Interdisciplinary Communication
1
2019
201
0.530
 Why?
Medical Order Entry Systems
1
2018
40
0.520
 Why?
Child, Preschool
20
2026
11868
0.520
 Why?
Cefoxitin
1
2017
8
0.510
 Why?
Gram-Negative Bacterial Infections
1
2017
49
0.510
 Why?
Cephalosporins
2
2015
45
0.500
 Why?
Ceftriaxone
1
2017
21
0.500
 Why?
beta-Lactams
1
2017
32
0.500
 Why?
Gram-Positive Bacterial Infections
1
2017
72
0.490
 Why?
Interprofessional Relations
1
2019
276
0.490
 Why?
Prescriptions
1
2016
74
0.480
 Why?
Pneumonia, Bacterial
1
2017
113
0.480
 Why?
Drug Costs
1
2017
117
0.480
 Why?
Pyomyositis
3
2022
15
0.480
 Why?
Communicable Diseases
4
2021
166
0.460
 Why?
Exanthema
1
2016
86
0.450
 Why?
Neutropenia
1
2016
154
0.450
 Why?
Mycobacterium tuberculosis
4
2021
318
0.440
 Why?
Diarrhea
1
2016
193
0.440
 Why?
Thimerosal
2
2005
6
0.430
 Why?
Health Resources
1
2016
130
0.430
 Why?
Preservatives, Pharmaceutical
2
2005
28
0.420
 Why?
Enterovirus D, Human
1
2016
87
0.420
 Why?
Inpatients
4
2021
553
0.420
 Why?
Disease Outbreaks
2
2021
419
0.400
 Why?
Decision Support Systems, Clinical
1
2018
273
0.400
 Why?
Enterovirus Infections
1
2016
173
0.390
 Why?
Cephalexin
2
2024
14
0.380
 Why?
Electronic Health Records
2
2019
1202
0.380
 Why?
Guideline Adherence
1
2017
587
0.380
 Why?
Inappropriate Prescribing
1
2013
66
0.380
 Why?
Pandemics
2
2022
1711
0.370
 Why?
Cross Infection
3
2025
260
0.360
 Why?
Trachea
2
2026
258
0.360
 Why?
Intensive Care Units, Pediatric
3
2025
288
0.340
 Why?
Health Personnel
1
2018
757
0.330
 Why?
Referral and Consultation
1
2017
868
0.320
 Why?
Vancomycin
2
2023
95
0.320
 Why?
Liver Abscess, Amebic
2
2009
3
0.310
 Why?
Phospholipases A
2
2007
97
0.300
 Why?
Urinary Tract Infections
2
2025
210
0.300
 Why?
Practice Guidelines as Topic
1
2017
1582
0.290
 Why?
Stomach Rupture
1
2009
3
0.290
 Why?
Phospholipases
1
2009
14
0.290
 Why?
Thiolester Hydrolases
1
2009
13
0.290
 Why?
Male
28
2026
73003
0.290
 Why?
Pericardial Effusion
1
2009
22
0.290
 Why?
Lactones
1
2009
59
0.280
 Why?
Staphylococcus aureus
5
2024
453
0.280
 Why?
Peritonitis
1
2009
83
0.270
 Why?
Pleural Effusion
1
2009
59
0.270
 Why?
Diphtheria-Tetanus-Pertussis Vaccine
2
2005
28
0.270
 Why?
Colorado
4
2020
4556
0.270
 Why?
Drug Utilization
3
2017
168
0.270
 Why?
Cefadroxil
2
2024
8
0.250
 Why?
Carboxylic Ester Hydrolases
1
2007
24
0.250
 Why?
Female
25
2026
79035
0.250
 Why?
Gene Expression Regulation, Bacterial
2
2009
337
0.250
 Why?
Cost Savings
2
2017
86
0.250
 Why?
Time Factors
4
2024
7133
0.240
 Why?
Dermatomycoses
1
2006
8
0.240
 Why?
Infant, Newborn
7
2025
6464
0.230
 Why?
Mycobacterium
1
2007
101
0.230
 Why?
Pharmacy Service, Hospital
2
2017
89
0.230
 Why?
Adolescent
15
2025
22573
0.230
 Why?
Drug Approval
1
2006
93
0.230
 Why?
Immunoglobulins, Intravenous
1
2006
133
0.220
 Why?
Infection Control
3
2015
173
0.220
 Why?
Intellectual Property
1
2005
7
0.220
 Why?
Autistic Disorder
2
2005
219
0.220
 Why?
Measles
1
2025
46
0.210
 Why?
Specimen Handling
1
2026
183
0.210
 Why?
Mycoses
1
2025
88
0.210
 Why?
Simplexvirus
1
2004
82
0.210
 Why?
Encephalitis, Viral
1
2004
45
0.210
 Why?
Limbus Corneae
1
2023
8
0.200
 Why?
Amoxicillin
1
2024
35
0.200
 Why?
Bacterial Proteins
2
2018
968
0.200
 Why?
Herpes Simplex
1
2004
99
0.200
 Why?
Lymphadenitis
1
2023
6
0.190
 Why?
Drug Administration Schedule
3
2017
782
0.190
 Why?
Hospitalization
5
2023
2460
0.190
 Why?
Drainage
2
2017
185
0.190
 Why?
Cisplatin
1
2024
345
0.190
 Why?
Extracellular Vesicles
1
2025
171
0.180
 Why?
Exosomes
1
2023
104
0.180
 Why?
Databases, Factual
4
2025
1491
0.180
 Why?
Exudates and Transudates
1
2021
12
0.180
 Why?
Machine Learning
2
2025
587
0.180
 Why?
Cross-Over Studies
1
2024
610
0.170
 Why?
Immunotherapy
1
2006
667
0.170
 Why?
Fluoroquinolones
1
2021
44
0.170
 Why?
Risk Adjustment
1
2021
85
0.170
 Why?
Fever
2
2017
319
0.160
 Why?
Mucocutaneous Lymph Node Syndrome
1
2021
94
0.160
 Why?
Antibiotic Prophylaxis
1
2022
134
0.160
 Why?
Bone Diseases, Infectious
1
2020
8
0.160
 Why?
Hospitals
3
2021
733
0.160
 Why?
Delayed Diagnosis
1
2021
100
0.160
 Why?
Treatment Outcome
7
2024
11793
0.160
 Why?
Meningitis
1
2021
80
0.160
 Why?
Laboratories
1
2021
110
0.150
 Why?
Molecular Diagnostic Techniques
2
2020
104
0.150
 Why?
Bacteroides fragilis
1
2019
14
0.150
 Why?
Encephalitis
1
2021
142
0.150
 Why?
Appendectomy
2
2017
90
0.150
 Why?
Monte Carlo Method
1
2019
148
0.150
 Why?
Drug Resistance, Neoplasm
1
2024
883
0.140
 Why?
Autophagy
1
2021
291
0.140
 Why?
Neisseriaceae Infections
1
2018
6
0.140
 Why?
Pediatrics
3
2017
1125
0.140
 Why?
Antibodies, Monoclonal
1
2006
1505
0.140
 Why?
Entamoeba histolytica
2
2009
9
0.140
 Why?
Area Under Curve
1
2019
332
0.140
 Why?
Hospital Records
1
2018
10
0.140
 Why?
Reactive Oxygen Species
1
2021
611
0.140
 Why?
Proteomics
1
2025
1188
0.140
 Why?
Drug Therapy, Combination
2
2021
1043
0.140
 Why?
Induced Pluripotent Stem Cells
1
2021
273
0.130
 Why?
Medical Records Systems, Computerized
1
2018
95
0.130
 Why?
Hydrolysis
2
2009
197
0.130
 Why?
Tuberculosis
1
2021
284
0.130
 Why?
Sequence Homology, Amino Acid
2
2009
387
0.130
 Why?
Combined Modality Therapy
2
2017
1270
0.130
 Why?
United States
10
2026
16123
0.130
 Why?
MicroRNAs
1
2023
686
0.130
 Why?
Patient Readmission
3
2017
772
0.130
 Why?
Abdominal Abscess
1
2017
26
0.130
 Why?
Abscess
1
2017
77
0.120
 Why?
Central Venous Catheters
1
2017
53
0.120
 Why?
Medical Records
1
2017
192
0.120
 Why?
Administration, Oral
2
2016
867
0.120
 Why?
Communicable Disease Control
1
2017
86
0.120
 Why?
Drug Substitution
1
2017
63
0.120
 Why?
Drug Resistance
1
2017
145
0.120
 Why?
Amino Acid Sequence
4
2009
2131
0.120
 Why?
Osteoarthritis
1
2018
200
0.120
 Why?
Drug Prescriptions
1
2018
288
0.120
 Why?
Pharmacists
1
2019
258
0.120
 Why?
Molecular Sequence Data
4
2009
2883
0.120
 Why?
Rural Population
1
2021
661
0.120
 Why?
Sensitivity and Specificity
3
2025
2000
0.110
 Why?
Aftercare
1
2017
222
0.110
 Why?
Administration, Intravenous
1
2016
172
0.110
 Why?
Cell Wall
2
2021
57
0.110
 Why?
Community-Acquired Infections
1
2017
177
0.110
 Why?
Length of Stay
2
2020
1350
0.110
 Why?
Knowledge Management
1
2014
2
0.110
 Why?
Radiography
1
2017
853
0.110
 Why?
Diabetes Mellitus
1
2023
1101
0.110
 Why?
Clostridium Infections
1
2015
74
0.110
 Why?
Prospective Studies
3
2024
8075
0.100
 Why?
Medication Therapy Management
1
2014
72
0.100
 Why?
Postoperative Care
1
2016
286
0.100
 Why?
Cost-Benefit Analysis
1
2017
644
0.100
 Why?
Antitubercular Agents
2
2021
208
0.100
 Why?
Antineoplastic Agents
1
2024
2219
0.100
 Why?
Acute Kidney Injury
1
2021
874
0.100
 Why?
Tomography, X-Ray Computed
3
2009
2770
0.090
 Why?
Ambulatory Care
1
2017
610
0.090
 Why?
Drug Monitoring
1
2016
401
0.090
 Why?
Bacteria
3
2023
766
0.090
 Why?
Quality of Health Care
1
2017
693
0.090
 Why?
Genotype
3
2021
1857
0.090
 Why?
Drug Hypersensitivity
1
2013
90
0.090
 Why?
Laparoscopy
1
2017
481
0.090
 Why?
Risk Assessment
2
2016
3752
0.090
 Why?
Physicians
1
2019
956
0.080
 Why?
Cohort Studies
2
2017
6032
0.080
 Why?
Patient Education as Topic
1
2014
777
0.070
 Why?
Paromomycin
1
2009
3
0.070
 Why?
Mycolic Acids
1
2009
6
0.070
 Why?
Trophozoites
1
2009
4
0.070
 Why?
Young Adult
4
2021
14251
0.070
 Why?
Antiprotozoal Agents
1
2009
15
0.070
 Why?
Attitude of Health Personnel
1
2017
1197
0.070
 Why?
Practice Patterns, Physicians'
1
2018
1372
0.070
 Why?
DNA, Protozoan
1
2008
32
0.070
 Why?
Dose-Response Relationship, Drug
2
2017
2028
0.070
 Why?
Tuberculosis, Pulmonary
1
2009
127
0.070
 Why?
Nitrobenzenes
1
2007
15
0.060
 Why?
Chromatography, Thin Layer
1
2007
24
0.060
 Why?
Polysorbates
1
2007
42
0.060
 Why?
Cell Line, Tumor
2
2025
3551
0.060
 Why?
Terminology as Topic
1
2009
259
0.060
 Why?
Injections, Intravenous
2
2017
197
0.060
 Why?
Gentian Violet
1
2026
4
0.060
 Why?
Membrane Lipids
1
2007
82
0.060
 Why?
Phenazines
1
2026
17
0.060
 Why?
Animals
6
2024
38097
0.060
 Why?
Maximum Tolerated Dose
1
2006
211
0.060
 Why?
Selection, Genetic
1
2008
263
0.060
 Why?
Recombinant Proteins
1
2009
1368
0.060
 Why?
Measles Vaccine
1
2025
19
0.060
 Why?
Enzyme Inhibitors
1
2009
821
0.060
 Why?
United States Food and Drug Administration
1
2006
208
0.060
 Why?
Aminopeptidases
1
2024
20
0.050
 Why?
Ethylmercury Compounds
1
2004
1
0.050
 Why?
Diphtheria-Tetanus Vaccine
1
2004
5
0.050
 Why?
Methylmercury Compounds
1
2004
9
0.050
 Why?
Risk Factors
2
2016
10917
0.050
 Why?
Drug Industry
1
2005
49
0.050
 Why?
Mass Spectrometry
2
2025
731
0.050
 Why?
Aphasia
1
2004
24
0.050
 Why?
Escherichia coli
1
2009
835
0.050
 Why?
Diagnosis, Differential
1
2009
1512
0.050
 Why?
North America
1
2025
303
0.050
 Why?
Half-Life
1
2004
155
0.050
 Why?
Streptococcus pyogenes
1
2004
41
0.050
 Why?
Amoxicillin-Potassium Clavulanate Combination
1
2024
16
0.050
 Why?
Patient Discharge
2
2025
995
0.050
 Why?
Acyclovir
1
2004
98
0.050
 Why?
Child Development Disorders, Pervasive
1
2004
65
0.050
 Why?
Adult
5
2021
40872
0.050
 Why?
Hematologic Neoplasms
1
2006
168
0.050
 Why?
Reproducibility of Results
2
2023
3416
0.050
 Why?
beta-Lactamases
1
2024
53
0.050
 Why?
Vomiting
1
2004
131
0.050
 Why?
Kinetics
1
2007
1568
0.050
 Why?
Sulbactam
1
2023
6
0.050
 Why?
Stromal Cells
1
2023
121
0.050
 Why?
Ampicillin
1
2023
17
0.050
 Why?
Nasopharynx
1
2023
72
0.050
 Why?
Haemophilus influenzae
1
2023
68
0.050
 Why?
Multiplex Polymerase Chain Reaction
1
2023
56
0.050
 Why?
Pneumonia
1
2009
636
0.050
 Why?
Cephalothin
1
2022
5
0.050
 Why?
Oxacillin
1
2022
5
0.050
 Why?
Type C Phospholipases
1
2002
69
0.050
 Why?
Methicillin
1
2022
10
0.050
 Why?
Cefazolin
1
2022
22
0.050
 Why?
Cornea
1
2023
154
0.050
 Why?
Butanes
1
2021
3
0.040
 Why?
Cell Extracts
1
2021
19
0.040
 Why?
DNA Glycosylases
1
2021
10
0.040
 Why?
Single-Cell Analysis
1
2025
361
0.040
 Why?
Gestational Age
1
2025
989
0.040
 Why?
Cell Communication
1
2023
327
0.040
 Why?
Ubiquinone
1
2021
35
0.040
 Why?
Pyridinium Compounds
1
2021
31
0.040
 Why?
Autophagy-Related Proteins
1
2021
46
0.040
 Why?
Streptococcus pneumoniae
1
2023
186
0.040
 Why?
Developmental Disabilities
1
2004
281
0.040
 Why?
Megakaryocytes
1
2021
34
0.040
 Why?
Arkansas
1
2021
23
0.040
 Why?
Reference Standards
1
2021
177
0.040
 Why?
Microbiology
1
2021
24
0.040
 Why?
Organophosphorus Compounds
1
2021
84
0.040
 Why?
Staining and Labeling
1
2021
153
0.040
 Why?
NLR Family, Pyrin Domain-Containing 3 Protein
1
2021
166
0.040
 Why?
Seizures
1
2004
485
0.040
 Why?
Drug Combinations
1
2021
396
0.040
 Why?
Ubiquitin-Protein Ligases
1
2021
194
0.040
 Why?
Myositis
1
2020
57
0.040
 Why?
Coronary Vessels
1
2021
246
0.040
 Why?
Pseudomonas aeruginosa
1
2002
395
0.040
 Why?
Neoplasms
2
2025
2913
0.040
 Why?
Diagnostic Errors
1
2020
178
0.040
 Why?
Feces
2
2015
496
0.040
 Why?
Clindamycin
1
2018
14
0.040
 Why?
Gene Expression Regulation, Neoplastic
1
2024
1450
0.030
 Why?
Developed Countries
1
2018
38
0.030
 Why?
Hospital Charges
1
2018
46
0.030
 Why?
Leukocytes, Mononuclear
1
2021
574
0.030
 Why?
Cross-Sectional Studies
2
2021
5922
0.030
 Why?
Bacteriological Techniques
1
2018
66
0.030
 Why?
Methyltransferases
1
2018
75
0.030
 Why?
Research Design
1
2004
1139
0.030
 Why?
Medical Staff, Hospital
1
2018
80
0.030
 Why?
Prostatic Neoplasms
1
2025
981
0.030
 Why?
Controlled Before-After Studies
1
2017
15
0.030
 Why?
Metformin
1
2021
329
0.030
 Why?
Age Distribution
1
2018
404
0.030
 Why?
Sex Distribution
1
2018
388
0.030
 Why?
Blood Platelets
1
2021
379
0.030
 Why?
Epithelial Cells
1
2023
1134
0.030
 Why?
Benchmarking
1
2018
191
0.030
 Why?
Arthritis, Rheumatoid
1
2006
1180
0.030
 Why?
Vaccination
1
2025
1428
0.030
 Why?
Mice
2
2021
18355
0.030
 Why?
Myocardium
1
2021
935
0.030
 Why?
Comorbidity
1
2021
1662
0.030
 Why?
Genomics
1
2021
830
0.030
 Why?
Lung
1
2009
4116
0.030
 Why?
Early Diagnosis
1
2016
251
0.030
 Why?
Algorithms
1
2023
1850
0.030
 Why?
Asthma
1
2006
1797
0.030
 Why?
Recurrence
1
2017
1139
0.030
 Why?
Alcoholism
1
2021
826
0.030
 Why?
Inservice Training
1
2014
118
0.030
 Why?
Kidney
1
2021
1496
0.020
 Why?
Polymorphism, Single Nucleotide
1
2021
2181
0.020
 Why?
Cell Differentiation
1
2021
2050
0.020
 Why?
Substrate Specificity
2
2004
387
0.020
 Why?
Medical Oncology
1
2015
340
0.020
 Why?
Brain
1
2004
2969
0.020
 Why?
Hypoglycemic Agents
1
2021
1399
0.020
 Why?
Disease Models, Animal
1
2021
4568
0.020
 Why?
Dysentery, Amebic
1
2008
2
0.020
 Why?
Surveys and Questionnaires
1
2021
6085
0.020
 Why?
Case-Control Studies
1
2015
3634
0.020
 Why?
Polymerase Chain Reaction
1
2008
1043
0.010
 Why?
Prophages
1
2004
8
0.010
 Why?
Structure-Activity Relationship
1
2004
563
0.010
 Why?
Postoperative Complications
1
2016
2977
0.010
 Why?
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
1
2002
143
0.010
 Why?
Electrophoresis, Polyacrylamide Gel
1
2002
331
0.010
 Why?
Choline
1
2002
138
0.010
 Why?
Alleles
1
2004
896
0.010
 Why?
Phospholipids
1
2002
214
0.010
 Why?
Base Sequence
1
2004
2171
0.010
 Why?
Hemolysis
1
2002
242
0.010
 Why?
Calcium
1
2002
1191
0.010
 Why?
Aged
1
2009
26215
0.000
 Why?
Middle Aged
1
2009
36302
0.000
 Why?
Parker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (344) concept(s)
_
Co-Authors Expand Description
See all (56) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)